April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
577 nm Yellow Selective Subthreshold Laser Photocoagulation for the Treatment of Central Serous Chorioretinopathy with Foveal Leakage
Author Affiliations & Notes
  • Alessandro J. Dare
    Ophthalmology, CBEO, Ribeirao Preto, Brazil
  • Jose A. Cardillo
    Hospital de Olhos de Araraquara, Araraquara, Brazil
  • Daniel Lavinsky
    Ophthalmology, Vision Institute UNIFESP, Sao Paulo, Brazil
  • Rubens Belfort, Jr.
    Ophthalmology, Federal University of Sao Paulo, Sao Paulo, Brazil
  • Carlos E. Moreira
    Ophthalmology, CBEO, Araraquara, Brazil
  • Footnotes
    Commercial Relationships  Alessandro J. Dare, None; Jose A. Cardillo, None; Daniel Lavinsky, None; Rubens Belfort, Jr., None; Carlos E. Moreira, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 6622. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alessandro J. Dare, Jose A. Cardillo, Daniel Lavinsky, Rubens Belfort, Jr., Carlos E. Moreira; 577 nm Yellow Selective Subthreshold Laser Photocoagulation for the Treatment of Central Serous Chorioretinopathy with Foveal Leakage. Invest. Ophthalmol. Vis. Sci. 2011;52(14):6622.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To report the visual and clinical outcomes of subthreshold 577-nm micro-pulsed laser photocoagulation (SMLP) technique for chronic idiopathic central serous chorioretinopathy (ICSC) with focal foveal leakage or chronic diffuse leakage with foveal involvement.

Methods: : Nine eyes with ICSC with duration longer than 4 months with focal foveal leakage or with diffuse leakage involving the fovea were treated. High density focal laser were delivered targeting the angiographic leakage points (including the central foveal area) as well as the adjacent normal retina. Main outcomes were change in ETDRS best correct visual acuity and central macular thickness measured using optical coherence tomography. Patients were followed 1, 2, 3, and 6-months after treatment. Pre and post-treatment fluorescein angiography (FA) and microperimetry were assessed.

Results: : No visible clinical signs of treatment could be detected either on fundus examination or FA. Microperimetry examination showed no induced laser-related focal damage to the treated area. Improvement of 3 or more lines on the ETDRS chart was achieved in 6 (67%) of the patients. At the last follow-up visit, subretinal fluid were completely resolved in 8 (89%) eyes. One third of the eyes (3 eyes) needed to be re-treated.

Conclusions: : This selective SMLP therapeutic technique using the 577 nm yellow laser applied to foveal leakage with extension to diffuse affected as well as normal retina areas enable a selective and optimized approach, providing a possible more comprehensive laser therapeutic strategy for the treatment of ICSC patients with foveal leakage, with no laser-induced damage.

Keywords: laser • retina • retina 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.